Original language | English (US) |
---|---|
Pages (from-to) | 761-767 |
Number of pages | 7 |
Journal | Cancer Investigation |
Volume | 18 |
Issue number | 8 |
DOIs | |
State | Published - 2000 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Cancer Investigation, Vol. 18, No. 8, 2000, p. 761-767.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Palliative medicine
T2 - An emerging field of specialization
AU - Von Gunten, Charles F.
AU - Muir, J. Cameron
N1 - Funding Information: also increasing efforts to improve end-of-life care from philanthropic efforts. The Open Society’s Project on Death in America has funded both research programs and the development of leaders in end-of-life care. The Robert Wood Johnson Foundation has committed $46 million to fund a variety of projects to improve the care of the dying in the United States. At the governmental institutional level, there is new funding allocated through the National Cancer Institute for education and research efforts in palliative care. There is also industry support of improvements in symptom management with such efforts as the Palliative Care Institute of Roxane Laboratories, Inc. that funds a variety of educational initiatives in pain and symptom management in the United States. Clearly, there is a strong societal and professional need for standards of competence in end-of-life care, including the development of palliative medicine as a physician specialty. There is also significant physician interest in seeking professional recognition for their expertise in caring for terminally ill persons and their families. We are confident that this certification process recognizes a level of knowledge and the skills necessary for the comprehensive practice of hospice and palliative medicine in the United States. It is the goal of the ABHPM to certify fellowship programs in hospice and palliative medicine nationally. We look forward to watching the cadre of professionals in this field grow as we meet the challenges of caring for patients with progressive disease for whom the prognosis is limited and the focus of care is quality of life.
PY - 2000
Y1 - 2000
UR - http://www.scopus.com/inward/record.url?scp=0033671574&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033671574&partnerID=8YFLogxK
U2 - 10.3109/07357900009012208
DO - 10.3109/07357900009012208
M3 - Article
C2 - 11107446
AN - SCOPUS:0033671574
SN - 0735-7907
VL - 18
SP - 761
EP - 767
JO - Cancer Investigation
JF - Cancer Investigation
IS - 8
ER -